Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.67 | N/A | +1.36% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.67 | N/A | +1.36% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS performance, indicating a strong operational focus. However, they did not provide specific guidance for future quarters.
We are pleased with our performance this quarter despite not providing specific guidance.
Our focus remains on delivering value to our customers and driving innovation.
Agilent Technologies reported a slight beat on EPS, which contributed to a modest increase in stock price. The lack of revenue data and guidance may leave investors cautious, but management's positive tone suggests confidence in ongoing operations. The stock's slight uptick reflects a generally favorable reception to the earnings report.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMKOR TECHNOLOGY INC
Feb 10, 2014